Cephas Life Sciences Private Limited, a active private limited company, was established on 22 July 2019 in Chennai, Tamil Nadu, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73100TN2019PTC130646. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.36 Cr and a paid-up capital of ₹1.36 Cr.
Its leadership includes Thangiah Immanuel (Director), Benjamin Philip Ashok Karunakaran (Whole-Time Director), Rajakumari Bagavath Singh (Director). Past directors included Benjamin Philip Ashok Karunakaran. It holds ₹7.56 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Module 313 And 314, Phase I, Iii Floor Ticel Bio Park Limited No 5 Csir Road, T, Aramani, Chennai, Tamil Nadu, 600113.
U73100TN2019PTC130646
130646
22 July 2019
₹1.36 Cr
₹1.36 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Cephas Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thangiah Immanuel | Director | 22 Jul 2019 | Current |
| Benjamin Philip Ashok Karunakaran | Whole-Time Director | 22 Jul 2019 | Current |
| Rajakumari Bagavath Singh | Director | 22 Jul 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cephas Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 3579.53% increase. The company also saw a substantial improvement in profitability, with a 966.72% increase in profit. The company's net worth moved up by a moderate rise of 7.21%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Cephas Life Sciences had a promoter holding of 17.29% and a public holding of 82.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹75,640,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2025 | Others | ₹4.30 M | Open |
| 06 Jun 2025 | Axis Bank Limited | ₹1.70 Cr | Open |
| 31 Jul 2024 | Sidbi | ₹5.00 M | Open |
| 08 Feb 2022 | Sidbi | ₹2.84 M | Open |
| 16 Nov 2020 | Indian Bank | ₹1.50 Cr | Open |
Explore comprehensive loan charge details -
Cephas Life Sciences has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cephas Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cephas Life Sciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Others amounted to Rs. 0.43 Cr with Charge ID 101168592 was registered on 30 Sep 2025. was documented.
Progress on A charge with Axis Bank Limited amounted to Rs. 1.70 Cr with Charge ID 101129500 was registered on 06 Jun 2025. was documented.
Progress on Cephas Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity A charge with Sidbi amounted to Rs. 0.50 Cr with Charge ID 100958573 was registered on 31 Jul 2024. was completed.
Progress on Cephas Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
A charge with Indian Bank of Rs. 1.50 Cr registered on 16 Nov 2020 with Charge ID 100389095 was modified on 14 Sep 2023. was recorded as a recent event.
The CIN of Cephas Life Sciences Private Limited is U73100TN2019PTC130646.
Cephas Life Sciences Private Limited is headquartered at Module 313 And 314, Phase I, Iii Floor Ticel Bio Park Limited No 5 Csir Road, T, Aramani, Chennai, Tamil Nadu, 600113.
Cephas Life Sciences Private Limited was incorporated on 22 July 2019.
The current directors of Cephas Life Sciences Private Limited are
The primary industry of Cephas Life Sciences Private Limited is Professional, Scientific And Technical.
Cephas Life Sciences Private Limited is unlisted.
The authorized capital of Cephas Life Sciences Private Limited is ₹1.36 Cr, and the paid-up capital is ₹1.36 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX